Cardiex Limited

15/10/2025

Cardiex is now CONNEQT Health.

Driving the future of arterial health.

We’ve brought together our mission, team, and technology to deliver innovation across home, clinical, and research settings. The result is more personalized, proactive care for every stage of cardiovascular health.

We’re shaping the future of cardiovascular care through Arterial Intelligence™.

🔗 Follow on your favorite platform:
Instagram | Facebook | X | LinkedIn | YouTube

📍 Now trading on the ASX as CQT

Conneqt Health

29/09/2025

A New Era in Arterial Health

Cardiex is now CONNEQT Health.

One name. One mission. One vision for the future of arterial health.

We’re uniting our mission and innovation under a single name as we build the first connected ecosystem for arterial health.

This change brings clarity to our platform, strengthens our identity, and reflects the growing momentum of our Pulse arterial health monitor across homes, clinics, and research.

It’s more than a name change. It’s a step forward in making proactive, personalized cardiovascular care more accessible than ever.

📰 Read the full announcement:https://announcements.asx.com.au/asxpdf/20250923/pdf/06pk0f90bw0y8n.pdf

$CQT Conneqt Health

26/04/2023

CardieX (ASX:CDX) subsidiary CONNEQT Health has been granted 510(k) clearance by the United States Food and Drug Administration (FDA) for the CONNEQT Pulse, a world-first vascular biometric monitor that provides both brachial and central blood pressure measurements along with multiple other biometric parameters not available in traditional blood pressure monitors.

CardieX CEO, Craig Cooper, commented: “CONNEQT Pulse’s 510(k) clearance by the FDA marks a major milestone in the field of cardiovascular health management. We’re thrilled to offer individuals with hypertension and other vascular diseases an innovative new way to monitor their arterial health at home with the same tools the country’s top cardiologists use in their research facilities and clinics. At launch, there won’t be any other vital signs monitor that provides the level of features, personalization, or vascular health insights that will be available on the Pulse. This technology has the potential to truly revolutionize the way hypertension and vascular disease are diagnosed and managed in the future.”

Read the full story here: https://tinyurl.com/2y7pdu2p

04/04/2022

The entire CardieX team is thrilled to welcome health and fitness leaders Jack Seitz and Lara Rosenbaum to the executive team of CardieX's subsidiary CONNEQT, a new consumer health company that will focus on home vital signs monitors, wearables and consumer health apps.

These new hires come at a time when CONNEQT is developing its first products, which will begin launching later this year. The first to market will be the CONNEQT "Pulse" – a dual blood pressure monitor anticipated to be the first consumer vital signs monitor to measure central blood pressure using CardieX's patented SphygmoCor® technology. Additionally, CONNEQT will be branching shortly thereafter into the health wearable space with the CONNEQT Band, which will include a full suite of patented health parameters and unique health and wellness features focused on heart health.

/PRNewswire/ -- CardieX Limited (ASX: CDX), a global health technology company focused on cardiovascular disease and vascular health disorders, today announces...

01/04/2022

We're thrilled to be featured in the 's latest piece about . Heart disease is the number one cause of death globally, according to the World Health Organization.

Heart monitors are ubiquitous on wearable devices, and only growing more popular as a way for us to keep tabs on our health. But there’s a limit to what they can do.

29/03/2022

"Tic Watch GTH Pro: The that really cares about your ," as covered by

The new TicWatch GTH Pro smartwatch may be super affordable at US$99.99 a pop but it does save on features.

24/03/2022

"Low Cost Smartwatch Measures Heart Health Five Ways,"

Smartwatches have been in the mainstream for several years. The announcement of a new smartwatch generally doesn’t warrant coverage on Health Tech Insider unless the maker claims to have some…

22/03/2022

"Ticwatch GTH Pro Review | Impressive features for under £100," thanks for the review !

Reviewing the Mobvoi Ticwatch GTH Pro, an upgraded budget smartwatch now boasting unique heart fitness features. For under $100 US this affordable watch offe...

22/03/2022

Smartwatch Crunch breaks down the 's key features! Read more here:https://smartwatchcrunch.com/mobvoi-ticwatch-gth-pro-full-specification/

Mobvoi Ticwatch GTH Pro is the latest addition to Ticwatch's Series. This watch is purposefully priced below

16/03/2022

There is more to heart rate than just counting heartbeats. Discover your TruHR® and other personalized heart health insights – only on the all new TicWatch GTH Pro. Buy here: https://amzn.to/3pb3qT3